K. Karikó

Molecular Biology · 2004–2021

A researcher in the Science corpus: 13 papers; trusts 6 researchers and is trusted by 15 researchers here, as inferred from the citation graph.

Subfields

• Molecular Biology — 96 citations into it; #3,387 of 17,773 by trust here, #2,739 by citations
• Immunology — 63 citations into it; #635 of 2,160 by trust here, #517 by citations
• Cancer Research — 29 citations into it; #801 of 1,780 by trust here, #882 by citations

Whom K. Karikó trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. Hiromi Muramatsu
2. H. Hemmi
3. R. Medzhitov
4. D. Weissman
5. Houping Ni
6. Shizuo Akira

Who trusts K. Karikó overall

1. Ugur Sahin
2. Michael J. Hogan
3. N. Pardi
4. Misako Matsumoto
5. Joel S. Riley
6. Hiromi Muramatsu
7. Piotr S. Kowalski
8. Dongwan Kim
9. D. Weissman
10. Ö. Türeci

Papers from K. Karikó's perspective

Ordered by how strongly the researchers K. Karikó trusts endorse each paper. Same corpus, a different order for every researcher.

1. 5'-Triphosphate RNA Is the Ligand for RIG-I
2. Recognition of single-stranded RNA viruses by Toll-like receptor 7. (Proceedings of the National Academy of Sciences of the United States of America)
3. AAV Vector Integration Sites in Mouse Hepatocellular Carcinoma (Science)
4. A Toll-like receptor recognizes bacterial DNA (Nature)
5. Highly efficient reprogramming to pluripotency and directed differentiation of human cells using synthetic modified mRNA (Cell Stem Cell)
6. Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation (Nucleic Acids Research)
7. Expression of therapeutic proteins after delivery of chemically modified mRNA in mice (Nature Biotechnology)
8. Toll-like receptors and innate immunity (Nature reviews. Immunology)
9. Codon bias and heterologous protein expression. (Trends in Biotechnology)
10. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells (Nature Cell Biology)

Their papers

• Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. (2005) — 2,385 citations
• Sequence- and target-independent angiogenesis suppression by siRNA via TLR3 (2008) — 948 citations
• Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. (2008) — 1,650 citations
• Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes (2015) — 893 citations
• Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation (2010) — 616 citations
• mRNA-based therapeutics — developing a new class of drugs (2014) — 2,098 citations
• Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA (2011) — 816 citations
• BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans (2021) — 690 citations
• COVID-19 vaccine BNT162b1 elicits human antibody and TH1 T cell responses (2020) — 1,578 citations
• Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine (2020) — 87 citations
• Zika virus protection by a single low dose nucleoside modified mRNA vaccination (2017) — 808 citations
• DICER1 deficit induces Alu RNA toxicity in age-related macular degeneration (2011) — 615 citations
• mRNA Is an Endogenous Ligand for Toll-like Receptor 3* (2004) — 1,061 citations